TABLE 3.
Effect of MPA on the anti-VZV (wild-type and TK− strains) activities of ACV and GCV
Virus strain | Antiviral agent | EC50 (μg/ml)a
|
||||
---|---|---|---|---|---|---|
GCV alone | ACV alone | With MPA at 10 μg/ml | With MPA at 2.5 μg/ml | With MPA at 1.0 μg/ml | ||
OKA (TK+) | GCV | 0.86 ± 0.89 | 0.09 ± 0.09 | 0.11 ± 0.12 | 0.11 ± 0.12 | |
ACV | 0.45 ± 0.07 | 0.06 ± 0.04 | 0.05 ± 0.03 | 0.08 ± 0.02 | ||
YS-R (TK−) | GCV | 27 ± 31 | 1.5 ± 1.1 | 1.6 ± 1.0 | 1.4 ± 1.4 | |
ACV | 27 ± 20 | 0.8 ± 0.6 | 1.5 ± 0.7 | 0.55 ± 0.07 |
Data are mean values for two separate experiments. The EC50 of MPA alone is >10 μg/ml.